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Haemorrhagic septicaemia (HS) is an acute disease infecting cattle and 
buffaloes caused by Pasteurella multocida serotype B:2 which leads to great 
economic losses in countries with expanded animal industries such as Malaysia. 
This study was conducted to construct a mutant derived from the 921bp ABA392 
virulence gene in order to make avirulent P. multocida serotype B:2, thus 
making this P. multocida B:2 mutant a potential candidate for a live-attenuated 
vaccine against HS.  
 
The detection of a fragment which is related to P. multocida B:2 pathogenicity, 
the 921bp ABA392 virulence gene was carried out using Polymerase Chain 
Reaction (PCR) assay. Two P. multocida isolates, namely PMTB and 3030, 
isolated from a HS outbreak were used for PCR amplification. The particular 
921bp DNA fragment was found to be present in P. multocida B:2 genome as 
803bp in size. Sequencing of the recombinant plasmids confirmed that the 
803bp gene was 98% homologous to the reference sequence, the virulence 
921bp ABA392 DNA fragment.  
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Southern hybridization analysis revealed the 804bp of ABA392 gene was 
located at approximately 6kb position in the P. multocida B:2 genome. PCR 
performed towards the approximately 6kb DNA fragment produced an 803bp 
band which was confirmed to be the ABA392 virulence gene. The amplified PCR 
product was cloned and sequenced. Nucleotide sequences obtained were 98% 
identical to the reference strain, the 921bp ABA392 virulence gene. 
Pathogenicity test on the recombinant plasmids proved that the 804bp gene 
inserted within these plasmids still possessed the virulence properties of the 
921bp ABA392 gene which may lead to HS disease in cattle and buffaloes. 
 
In an attempt to produce P. multocida B:2 mutants through allelic exchange, the 
804bp of ABA392 gene which was disrupted with kanamycin cassette was 
cloned inside suicide plasmid pAKA19 through shotgun ligation technique. The 
desired 7kb product was transformed into several different E. coli (TOP 10, 
JM109, AS11Yλ and DH5α) hosts for preservation. Verification of the 7kb 
ligation product with digestion by PstI, HindIII and XhoI restriction enzymes 
revealed the exact sizes of kanamycin cassette (1.2kb), pAKA19 (5.0kb) and the 
disrupted 804bp of ABA392 virulence gene (804bp). An antibiotic sensitivity test 
on P. multocida B:2 and the respective E. coli strains were performed in order to 
select the donor and recipient strains for conjugation process. This test revealed 
that E. coli DH5α was suitable for the donor strain since it showed low 
resistance to streptomycin and P. multocida B:2 as the recipient strain for its 
high resistance towards streptomycin. Conjugation between donor and recipient 
strains was then achieved by plate-mating method. About 20 single colonies of 
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positive transconjugants were picked and subcultured on BHI blood agar 
containing kanamycin for 5 days to encourage loss of pAKA19 plasmid and to 
enhance the allelic exchange between the ABA392::KmR insert with the native 
ABA392 gene on the recipient chromosome. No plasmid was observed which 
indicated the loss of suicide plasmid. Direct colony PCR was performed to 
detect the changes in the ABA392 gene of the parent strain, where a 2kb band 
was observed signifying that allelic exchange has taken place and the organism 
is now a P. multocida B:2 mutants.  
 
Parent strains of P. multocida B:2 were highly virulent and killed mice within 24 
hours. Mice inoculated with P. multocida B:2 mutant survived. Direct smear from 
mice’s heart blood inoculated with the mutant showed the existence of bipolar 
organism which indicated the presence of P. multocida B:2. This result firmly 
suggests that the mutant, named as PMTBK was greatly attenuated and is thus 
a potential candidate organism for a live attenuated vaccine against HS.   
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Hawar berdarah (HS) merupakan penyakit akut yang menyerang lembu dan 
kerbau berpunca daripada bakteria Pasteurella multocida serotaip B:2 yang 
menyebabkan kemerosotan ekonomi bagi negara yang mempunyai industri 
penternakan berkembang maju seperti Malaysia. Kajian ini telah dijalankan 
untuk menghasilkan mutan avirulen daripada bakteria P. multocida B:2 terbitan 
daripada gen virulen ABA392 bersaiz 921bp, seterusnya menjadikan mutan ini 
calon yang berpotensi bagi penghasilan vaksin hidup teratenuat terhadap hawar 
berdarah.   
 
Pengesanan fragmen DNA yang berkait rapat dengan kepatogenan P. 
multocida B:2 iaitu gen virulen ABA392 bersaiz 921bp telah dijalankan melalui 
assai amplifikasi Tindakbalas Berantai Polymerase (PCR). Dua isolat P. 
multocida iaitu PMTB dan 3030 yang telah dipencilkan dari kawasan wabak 
penyakit hawar berdarah digunakan dalam amplifikasi PCR. Fragmen DNA 
bersaiz 921bp telah disahkan hadir dalam genom P. multocida B:2 dengan saiz 
803bp. Penjujukan terhadap plasmid rekombinan membuktikan bahawa gen 
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803bp adalah 98% homologous dengan jujukan rujukan iaitu fragmen DNA 
ABA392 yang virulen.     
 
Analisis penghibridan Southern menunjukkan gen ABA392 bersaiz 804bp 
terletak pada anggaran posisi 6kb dalam genom P. multocida B:2. Amplifikasi 
PCR ke atas fragmen DNA tersebut menghasilkan produk bersaiz 803bp lalu 
mengesahkan kehadiran gen virulen ABA392. Produk PCR ini kemudian diklon 
dan dijujuk di mana jujukan-jujukan nukleotida yang diperoleh adalah 98% 
seiras dengan jujukan rujukan iaitu gen virulen ABA392 bersaiz 921bp. Ujian 
kepatogenan ke atas plasmid rekombinan membuktikan gen 804bp yang telah 
disisipkan ke dalam plasmid tersebut masih mengekalkan ciri-ciri virulen dalam 
gen ABA392 bersaiz 921bp yang menyebabkan penyakit hawar berdarah pada 
lembu dan kerbau.  
 
Percubaan untuk menghasilkan mutan P. multocida B:2 melalui penukaran allel 
dijalankan melalui penyisipan kaset kanamycin ke dalam gen ABA392 bersaiz 
804bp dan diklon ke dalam plasmid pengorban pAKA19 menerusi teknik ligasi 
’shotgun’. Produk bersaiz 7kb yang diperoleh dipindahkan kepada beberapa 
perumah E. coli yang berbeza (TOP 10, JM109, AS11Yλ dan DH5α) untuk 
tujuan penyimpanan. Verifikasi ke atas produk ligasi bersaiz 7kb melalui 
tindakan pembatasan oleh enzim-enzim pembatas PstI, HindIII dan XhoI 
mengesahkan  kehadiran kaset kanamycin (1.2kb), pAKA19 (5.0kb) dan gen 
virulen gangguan ABA392 (804bp). Ujian sensitiviti terhadap antibiotik telah 
dijalankan ke atas P. multocida B: 2 dan strain-strain E. coli dalam usaha 
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memilih penderma dan penerima yang sesuai bagi proses konjugatan. E. coli 
DH5α telah didapati sesuai sebagai penderma kerana mempunyai kerintangan 
rendah terhadap streptomycin manakala P. multocida B:2 sebagai penerima 
kerana kerintangan tinggi terhadap streptomycin. Proses konjugatan antara 
penderma dan penerima dijalankan melalui kaedah plat pengawanan. Kira-kira 
20 koloni tunggal transkonjugan positif telah dipilih untuk disubkultur selama 5 
hari berturut-turut pada agar darah BHI bagi menggalakkan pelenyapan plasmid 
pAKA19, di samping menggalakkan penukaran allel di antara gen sisipan 
ABA392::KmR dan gen induk ABA392 pada kromosom penerima. 
Ketidakhadiran plasmid pAKA19 melalui elektroforesis agarose gel 
membuktikan plasmid tersebut telah berjaya dilenyapkan daripada gen 
gangguan 804bp. Aplikasi PCR secara langsung bagi mengesan perubahan 
dalam gen induk strain ABA392 menghasilkan jalur bersaiz 2kb menandakan 
berlakunya perubahan allel dan organisma tersebut kini adalah mutan P. 
multocida B:2. 
 
Strain induk P. multocida B:2 didapati amat virulen kerana strain ini membawa 
maut kepada tikus dalam tempoh 24 jam. Walau bagaimanapun, tikus yang 
telah diinokulat dengan mutan P. multocida B:2 didapati hidup. Saput terus 
daripada jantung tikus yang diinokulat dengan mutan menunjukkan kewujudan 
organisma dwikutub yang menandakan kehadiran P. multocida B:2. Keputusan 
ini dengan kuat mencadangkan bahawa mutan iaitu PMTBK adalah avirulen dan 
merupakan calon yang berpotensi untuk penghasilan vaksin teratenuat hidup 
terhadap hawar berdarah. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
Haemorrhagic septicaemia (HS) is an acute disease, mainly infecting cattle and 
water buffaloes. This disease is caused by two major serotypes of Pasteurella 
multocida, serotype B: 2 and E: 2 according to Carter-Heddleston classification, 
or serotype 6: B or 6: E based on Namioka-Carter classification. The first 
detailed report of an acute pasteurellosis, which affected deer, cattle and swine, 
has been attributed to Bollinger in 1878 who then reproduced the disease in 
cattle (Carter and de Alwis, 1989). 
 
The outbreaks of this disease are recorded in many countries and killed many 
cattle and buffaloes every year (Bain et al., 1982). This disease occurred in near 
and Middle East countries and in several parts in some regions of Africa (Carter 
and de Alwis, 1989). Moreover, it is also considered to be the most economically 
important disease of livestock in South East Asia and causes significant 
economic losses in India and Africa (Chandrasekaran et al., 1981). The latest 
occurrence of HS in Malaysia was reported in Perak in the year 2005 where the 
disease has been confirmed to be caused by Pasteurella multocida serotype B:2 
(Kamarudin, 2005). 
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HS has emerged as a disease of great economic importance. The annual losses 
of North American cattle industry due to HS was reported being approximately 
$US800 million (Verma and Jaiswal, 1997). In Malaysia, the production of 
quality livestock is always a major problem since the animals are constantly 
fraught with diseases, especially HS which threatens the quality of products 
(Saharee, 2005). This situation is hardening the government’s objective for 
livestock production to reach approximately RM 8 billion by 2010 (Mohd Nordin, 
2000). 
 
Vaccination has become the principal method of controlling HS in many 
countries. In Malaysia, vaccination is considered the most common and cheaper 
way of controlling outbreaks of HS (Zamri, 2005). Most commonly used vaccines 
in Malaysia are the alum-precipitated vaccine and the oil adjuvant vaccine. 
These vaccines did make an impact of increasing the immunity of animals 
against HS but still HS outbreaks and deaths remain (Dawkins et al., 1990). This 
may be due to the facts that those vaccines provide only short-term immunity 
and requires annual administration for effectiveness (Chandrasekaran et al., 
1994). 
 
A lot of research has been done in order to produce a better vaccine for this 
disease. It is widely recognized that an ideal vaccine should posses certain 
characteristics, such as; easy and economical to produce, stable for use in the 
tropics, easy to handle in the field with consistency that make it easy to 
administer, no adverse reactions, high level of immunity with a minimum delay 
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